MedTrace Logo

A Pharmacoeconomic Study Comparing the Use of Mycophenolate Mofetil or Cyclophosphamide as Induction Therapy in Lupus Nephritis Patients in Egypt

NCT05195086 · Status: COMPLETED · Type: OBSERVATIONAL · Enrollment: 122

Last updated 2022-01-18

No results posted yet for this study

Summary

The aim of this study is to conduct a pharmacoeconomic analysis to compare the use of Mycophenolate Mofetil or i.v. Cyclophosphamide as induction therapy from a third party payer perspective in LN patients in the Egyptian context

Conditions

Interventions

DRUG

endoxan

Immunosuppressant

DRUG

cellcept

Immunosuppressant

Sponsors & Collaborators

  • Nada Magdy Mansour

    lead OTHER

Eligibility

Min Age
18 Years
Max Age
65 Years
Sex
ALL
Healthy Volunteers
No

Timeline & Regulatory

Start
2018-07-01
Primary Completion
2020-01-01
Completion
2021-06-05
FDA Drug
Yes

Countries

  • Egypt

Study Locations

More Related Trials

Entities

Diseases

Read the full study record

This page highlights key information. For complete eligibility criteria, study locations, investigator contacts, and the full protocol, visit the original record on ClinicalTrials.gov.

View NCT05195086 on ClinicalTrials.gov